TGTX TG Therapeutics Inc

$TGTX I’m honestly amazed at how few ST active posters are here! And I also see it in the options chain- truly believe many have NOT caught on yet to this incredible company , and team MW has built! Win win Either we organically grow into a big pharma company OR get bought out by a big pharma company! Stock jumps 200-300% over the next 4-5 yrs OR we jump 70-100% overnight … WIN WIN 🏆 my biggest position and one I sleep well with at night unlike $SLS and $VKTX which manipulated to high hell !!!

$TGTX the first punch to $60 comes next week with the Toronto data presentations, the 2nd punch to $65 when revenue is posted early November, with updated (increased) guidance. The 3rd punch to $70-75 will be delivered late this year with the Sub Q phase 3 data readout. Of course, at any time a buyout could occur at $90-110. Shorts better have balls of steel, or an endless amount of cash to burn. This is not going to turn out well for you.

$TGTX The average price over the last 4 months is $54.15. If this isn't basing for another massive leg up, I don't know what to call this.

$TGTX There's another hurricane out there. It's going to turn into a CAT 5, and it's headed for TG shorts.

$TGTX SQ trial primary completion date is 10/31/26 (~2 weeks away), with results expected end of year or early next year. Hold strong longs!

$TGTX got myself some more at 52.80, still can't believe this has not been bought up yet. very bullish..

$TGTX we got late breaking oral. Great news. They dont give them for crap data. Enjoy the day folks.

$TGTX just saw on seeking alpha a list of 16 stocks with A+ growth > #13. TG Therapeutics, Inc. (TGTX) — Growth Grade: A+

$TGTX best in class! And cheaper, unless that changed recently. Should whip the competition.

$TGTX Mike has always said he believed this company to be worth north of $100 a Share , the longer this goes the higher the price , understand that this company is cash flow positive with improving margins !! Incredible growth ahead !!

$TGTX summary: TG Therapeutics (TGTX) – Positive News Summary TG Therapeutics announced encouraging five-year results for its multiple sclerosis drug, BRIUMVI. 44% lower relative risk of confirmed disability progression compared with Ocrevus. 49% lower relative risk compared with Kesimpta. Very low relapse rates maintained over five years. Commercial potential: Could help BRIUMVI gain market share against major competitors. Limitation: Results came from an indirect comparison, not a head-to-head clinical trial.

$TGTX Thinking it must be good news? “The event will feature significant presentations, including a late-breaking oral presentation on the initial clinical findings from the Phase 1 study of *azer-cel*, an allogeneic CD19-directed CAR T-cell therapy aimed at treating progressive multiple sclerosis (MS). This presentation, led by Daniel Ontaneda, MD, PhD, will take place on October 23. In addition, TG Therapeutics will showcase a range of data supporting its investigational therapy *BRIUMVI®* (ublituximab), which has demonstrated efficacy and safety in treating relapsing forms of MS. Key presentations include seven-year clinical outcome data, results from the Phase 3 ENHANCE trial evaluating a single-dose initiation regimen, and findings from real-world studies.”

$TGTX Cmon Mike…take the $110 offer and let’s move on. We would all be happy and then Big Pharma can get Briumvi out there faster to the people who really need it.

$TGTX perspective guys…ai trade is down ~50% and we are near all time highs with a catalyst rich 6 months ahead of us. Happy to be consolidating here

$TGTX good solid day of accumulation, looks still poised to break out over 60 at any time. Buying/adding on any dip, looking forward to big earnings growth ahead..

$TGTX What is wrong with you people? Do you not know to buy more when we dip! This too shall pass.

$TGTX been thru this bs 100 times since 2018. And we’re @ $50+ now not $4 or $8 Look at the big picture. This will keep going up. … buy dips.

$TGTX here we go again. Slow bleed pre earnings so they can cushion the report. If I said I’m not exhausted it would be lying! 😂 My favourite stock but 5 years of market BS on this has been a roller coaster to say the least. Roll on sub q

$TGTX I always ask question about why Mike never sold a single share out of his 14M+ shares. I guess we will find answers over the next 3 months with Sub-Q and Azer-cel.

$TGTX Catalyst next 180 day - BRIUMVI (MS) + azer-cel ENHANCE Ph3 positive (May) → sBLA targeted 2H 2026 (filing not yet confirmed) - SubQ BRIUMVI Ph3 enrolled; topline YE 2026 / early 2027 - Azer-cel Ph1 progressive MS: prelim data H2 2026 - Watch: schizophrenia Ph2 + MG Ph2 (enrollment only for now)